Category: United States
-
BMW seeks U.S. antisuit and anti-anti-antisuit injunction against NPE Onesta’s Munich lawsuit over two U.S. patents: Western District of Texas
The first-ever assertion of U.S. patents in a German court has now drawn, anything but unexpectedly, countermeasures in U.S. district court.
-
Teva removes more than 200 patents from U.S. FDA’s Orange Book: win for FTC
Following President Trump’s promise to lower the cost of drugs and a United States Federal Trade Commission investigation into a patent portfolio owned by Teva, the Israeli pharma company has asked the Food and Drug Administration to remove more than 200 improper patent listings related to asthma, diabetes, and COPD drugs, and epinephrine autoinjectors, from…
-
U.S. appeals court to Apple: now prove the value of your IP in district court (for the first time since the Samsung patent spat)
An appellate ruling that largely upheld contempt sanctions imposed on Apple will now lead to further proceedings in district court.
-
Target sued in Eastern District of Texas over payment system patent infringement
Cardtek (PayCore) has sued U.S. retailer Target in the United States Districs Court for the Eastern District of Texas over the alleged infringement of three of its patents related to payment systems.
-
Some direct patent infringement “acceptable price” for expediting competition: U.S. Solicitor General urges Supreme Court to review skinny labeling and generic drug access
United States Solicitor General D. John Sauer has filed a petition urging the Supreme Court to intervene in a long-running drug patent infringement case in which he alleges the Federal Circuit failed to apply the “skinny labelling” (section viii) pathway, which allows the entry of generics that carve out patented uses but otherwise duplicate the…
-
USPTO Director Squires encourages fairer, more consistent patent eligibility in latest memoranda
USPTO Director John A. Squires reminds applicants and examiners that when used properly, Subject-Matter Eligibility Declarations can be effective, encouraging examiners not to reject patent applications too broadly.
-
Infineon handed preliminary win in ITC patent infringement dispute against Innoscience
The United States International Trade Commission has issued a final initial determination finding that one of two gallium nitride patents that Infineon asserted against Chinese rival Innoscience has been infringed.
-
USPTO upholds core Proxense patent in Samsung, Apple, Microsoft, Google invalidation cases
Biometrics firm Proxense has bagged a key win in ongoing big tech patent litigation, after the United States Patent & Trademark Office upheld a key patent following a review requested by Samsung.
-
Federal Circuit tosses Pfizer’s $42M+8% verdict against Daiichi, AstraZeneca: claiming 81 combinations out of gazillions described defeats disclosure, enablement
In a precedential opinion, the central U.S. appeals court for patent rulings overturns a Texas jury verdict given the discrepancy between a broad description and a specific claim term.
-
USPTO Director Squires continues pro-patent enforcement march: IPR petition institutions remain low, submits first-ever public ITC comments
The United States Patent and Trademark Office’s low institution rate, together with its first-ever public comments to a United States International Trade Commission (ITC) investigation endorsing the ITC as a forum for adjudicating patents, underline Director John A. Squires’s pro-patent and pro-patent enforcement agenda.